Literature DB >> 2096698

Soluble phospholipase A2 in human pathology: clinical-laboratory interface.

W Pruzanski1, P Vadas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2096698     DOI： 10.1007/978-1-4613-0651-1_17

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  4 in total

1.  Identification of a specific region of low molecular weight phospholipases A2 (residues 21-40) as a potential target for structure-based design of inhibitors of these enzymes.

Authors:  E Cordella-Miele; L Miele; A B Mukherjee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

2.  Platelet-activating factor and phospholipase A2 in patients with septic shock and trauma.

Authors:  J Sörensen; B Kald; C Tagesson; M Lindahl
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

3.  Rat liver mitochondrial phospholipase A2 is an endotoxin-stimulated membrane-associated enzyme of Kupffer cells which is released during liver perfusion.

Authors:  G M Hatch; D E Vance; D C Wilton
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

4.  Induction of circulating group II phospholipase A2 expression in adults with malaria.

Authors:  P Vadas; J Keystone; E Stefanski; K Scott; W Pruzanski
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.